Back
Tompkins Financial Corp. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Buy
71
TMP
Tompkins Financial Corp.
Last Price:
$75.63
Seasonality Move:
0.01%
Sell
36
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.91
Seasonality Move:
-18.07%
Buy
71
Tompkins Financial Corp. (TMP)
is a Buy
Is Tompkins Financial Corp. a Buy, Sell or Hold?
-
The current Tompkins Financial Corp. [TMP] share price is $75.51. The Score for TMP is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
TMP is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $12.18. The Score for INKT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TMP Stock Price Chart
What is Tompkins Financial Corp.'s stock price today?
-
The Tompkins Financial Corp. share price today is $75.51Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMP is experiencing buying pressure, which is a positive indicator for future bullish movement.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $12.18Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
TMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.17 | Buy |
| Relative Strength Index (14 RSI): | 69.49 | Buy |
| Chaikin Money Flow: | 64341 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.59 - 72.91) | Buy |
| Bollinger Bands (100): | (64.43 - 70.41) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 49.45 | Sell |
| Chaikin Money Flow: | -21857 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.95) | Buy |
| Bollinger Bands (100): | (12.31 - 15.53) | Sell |
TMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.46 | Buy |
| 20-day SMA: | 70.28 | Buy |
| 50-day SMA: | 67.42 | Buy |
| 200-day SMA: | 64.93 | Buy |
| 8-day EMA: | 73.61 | Buy |
| 20-day EMA: | 71.25 | Buy |
| 50-day EMA: | 68.88 | Buy |
| 200-day EMA: | 66.02 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.34 | Sell |
| 20-day SMA: | 11.54 | Buy |
| 50-day SMA: | 13.05 | Sell |
| 200-day SMA: | 11.82 | Buy |
| 8-day EMA: | 12.2 | Sell |
| 20-day EMA: | 12.1 | Buy |
| 50-day EMA: | 12.75 | Sell |
| 200-day EMA: | 12.24 | Sell |
Tompkins Financial Corp. Earnings Growth & TMP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.49 per share, and an increase next year of $1.06 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Tompkins Financial Corp. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||